Assignee
YEE CASSIAN
US·4 granted patents·2 pending applications·5 citations·filing 2005–2022
Top patents by PatentIndex Score
6 records- 0183US9809797B2Enhanced generation of cytotoxic T-lymphocytes by IL-21 mediated FOXP3 suppressionYEE CASSIAN·Filed 2008·Granted Nov 7, 2017·5 cites·7 claims
- 0269US11052140B2Methods of treatment using conditional superagonist CTL ligands for the promotion of tumor-specific CTL responsesYEE CASSIAN·Filed 2019·Granted Jul 6, 2021·0 cites·20 claims
- 0357US10328135B2Method of obtaining cytolytic T cells by using mutant tumor epitopesYEE CASSIAN·Filed 2016·Granted Jun 25, 2019·0 cites·22 claims
- 0457US9314516B2Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responsesYEE CASSIAN·Filed 2011·Granted Apr 19, 2016·0 cites·15 claims
- 0556US2024293459A1Peptides and engineered t cell receptors targeting sars-cov-2 antigens and methods of useYEE CASSIAN·Filed 2022·Application pending·0 cites
- 0655US2006269973A1Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigensYEE CASSIAN·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →